Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-09-30Clinical Trial Update: A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis [Phase 4]
Phase 4 trial of brodalumab (KHK4827) for moderate to severe plaque psoriasis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-04-18Clinical Trial Update: Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients [Phase 4]
Clinical trial NCT03146247 evaluating itch pathogenesis in response to apremilast in plaque psoriasis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults [Phase 2]
A Phase 2 trial evaluating a botanical drug containing East Indian Sandalwood Oil for plaque psoriasis in adults has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-12-07Clinical Trial Update: GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis [Phase 3]
The Phase 3 vehicle-controlled study of GSK2894512 for adult plaque psoriasis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-05Clinical Trial Update: A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis [Phase 2]
A Phase 2 proof-of-concept study evaluating 0.5% roflumilast cream for mild-to-moderate plaque psoriasis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-11-29Clinical Trial Update: Post Marketing Observational Study on Venezuelan Patients With Psoriasis
A post-marketing observational study in Venezuelan patients with chronic plaque psoriasis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-09Clinical Trial Update: Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis [Phase 3]
Clinical trial update indicates that the Phase 3 efficacy study of Dimethyl Fumarate for moderate-to-severe plaque psoriasis has been withdr…
-
CLINICAL_TRIALS withdrawal · 2015-05-06Clinical Trial Update: TSO for Plaque Psoriasis [Phase 2]
A Phase 2 trial evaluating TSO for plaque psoriasis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-21Clinical Trial Update: Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis [Phase 4]
A Phase 4 trial of an injectable biologic with U0279 for severe plaque-type psoriasis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-15Clinical Trial Update: Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy [Phase 2]
Phase 2 clinical trial of apremilast for chronic plaque psoriasis in patients who failed biologic therapy was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-05-07Clinical Trial Update: To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis [Phase 3]
A Phase 3 trial evaluating NYC 0462 ointment for plaque psoriasis has been withdrawn. Sponsor Fougera Pharmaceuticals Inc.
-
CLINICAL_TRIALS withdrawal · 2011-10-21Clinical Trial Update: Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates. [Phase 1]
A Phase 1 open-label, single-dose study evaluating briakinumab's drug-drug interaction with CYP substrates in patients with plaque psoriasis…